Clinical Trial Update: A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aspirin for recurrence and survival in colon cancer patients undergoing adjuvant therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Leiden University | Conditions: Colon Cancer, Adjuvant Therapy | Phase 3 | Status: ACTIVE_NOT_RECRUITING